← Back to Search

Tailored Communication for COVID-19 Testing

N/A

Waitlist Available

Research Sponsored by Michigan State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

White, 18 or older

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 8 weeks

Awards & highlights

Study Summary

This trial will study how to better explain Covid-19 antibody testing to people in rural Michigan to get more people to do the test. #CovidTesting #RuralTesting

Who is the study for?

This trial is for white adults aged 18 or older living in rural Northern Michigan. It aims to understand how different communication strategies might influence their willingness to do a home-based saliva test for COVID-19 antibodies.Check my eligibility

What is being tested?

The study is testing two types of messages: general information about SARS-CoV-2 and tailored communication specifically designed for people in rural areas, to see which is more effective at promoting antibody testing using saliva samples.See study design

What are the potential side effects?

Since this trial focuses on communication methods rather than medical treatments, there are no direct side effects from interventions like drugs or vaccines. However, participants may experience discomfort or privacy concerns with home-based sample collection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years or older and identify as White.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Group-Based Medical Mistrust Outcomes

Home-Based Salivary Kit Request

Home-Based Salivary Test Kit Completion

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: White Rural: Rural-TargetedExperimental Treatment1 Intervention

White rural participants receive rural-targeted video information about SARS-CoV-2 antibody testing.

Group II: White Rural: GeneralActive Control1 Intervention

White rural participants receive "general consumption" video information about SARS-CoV-2 antibody testing.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Michigan State UniversityLead Sponsor

185 Previous Clinical Trials

601,810 Total Patients Enrolled

2 Trials studying COVID-19

705 Patients Enrolled for COVID-19

National Cancer Institute (NCI)NIH

13,660 Previous Clinical Trials

40,924,072 Total Patients Enrolled

39 Trials studying COVID-19

1,900,546 Patients Enrolled for COVID-19

Johns Hopkins UniversityOTHER

2,260 Previous Clinical Trials

14,820,580 Total Patients Enrolled

34 Trials studying COVID-19

26,775 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts underway for this trial?

"Indeed, clinicaltrials.gov states that this trial is still in need of participants and was last updated on October 10th 2023. This study was initially posted May 1st 2023 and requires 200 individuals to be recruited from 1 medical site."

Answered by AI

How many test subjects are participating in this clinical trial?

"Affirmative. According to information found on clinicaltrials.gov, the trial which was first uploaded on May 1st 2023 is still actively recruiting patients and has been updated most recently on October 10th 2023. 200 individuals need to be enrolled in this research from one location in particular."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva

Todd Lucas 2023. "Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06085547.